Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR0302 Ointment in Non-segmental Vitiligo (Phase II/III)
CTR20201418Phase 3Terminated
- Sponsor
- Reistone Biopharma
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivarmacitinib in Vitiligo, sponsored by Reistone Biopharma. Started Dec 2020; status: terminated.
02
Drugs
ivarmacitinib
03
Conditions
Vitiligo
Beyond the preview
Go deeper on CTR20201418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201418.